← Leaderboards
George S. Yap
Rutgers Biomedical And Health Sciences
$7,570,817
Attributed
$9,294,277
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $975K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,294,277 · 8
By mechanism
R01$7,115,132 · 3
R21$1,277,434 · 3
R56$901,711 · 2
Top collaborators
- William Clark Gause6 shared
Others in their field
Top investigators on “Toxoplasma Gondii”
- L David Sibley · Washington University$42,221,391
- John C Boothroyd · Stanford University$21,342,994
- Christopher A Hunter · University Of Pennsylvania$20,595,527
- Michael W White · University Of California Riverside$17,265,886
- Vernon Bruce Carruthers · Johns Hopkins University$15,672,870
- Gary E Ward · University Of Vermont & St Agric College$14,197,597
Research focus
Toxoplasma GondiiCellsImmune ResponseCytokineMediatingResponsePathogenImmunityInterleukin-10ToxoplasmosisInfectionInflammatorySignal TransductionInsightProgramsImmuneAntigensT-LymphocytePublishingTissuesMouse ModelParasitesInvestigationRegulation
Grant awards (26)
GDF-15 as a mediator of immune-regulated sickness response during infection$188,767
R21 · FY2024 · AI · contact PI
GDF-15 as a mediator of immune-regulated sickness response during infection$228,017
R21 · FY2023 · AI · contact PI
Induction of effector lymphocyte lethargy by helminth coinfection$587,042
R01 · FY2021 · AI · contact PI
Induction of effector lymphocyte lethargy by helminth coinfection$587,042
R01 · FY2020 · AI · contact PI
Induction of effector lymphocyte lethargy by helminth coinfection$587,042
R01 · FY2019 · AI · contact PI
Induction of effector lymphocyte lethargy by helminth coinfection$587,042
R01 · FY2018 · AI · contact PI
Toxoplasma entry receptors in the CNS$198,750
R21 · FY2018 · AI · contact PI
Induction of effector lymphocyte lethargy by helminth coinfection$587,042
R01 · FY2017 · AI · contact PI
Toxoplasma entry receptors in the CNS$238,500
R21 · FY2017 · AI · contact PI
Genesis of Defective Effector Lymphocytes in the Helminth-Coinfected Host$511,711
R56 · FY2016 · AI · contact PI
Pathogenic and Protective T cells in Toxoplasmosis$393,525
R01 · FY2014 · AI · contact PI
Pathogenic and Protective T cells in Toxoplasmosis$369,914
R01 · FY2013 · AI · contact PI
Pathogenic and Protective T cells in Toxoplasmosis$386,100
R01 · FY2012 · AI · contact PI
Pathogenic and Protective T cells in Toxoplasmosis$386,100
R01 · FY2011 · AI · contact PI
Pathogenic and Protective T cells in Toxoplasmosis$390,000
R01 · FY2010 · AI · contact PI
Regulation of Type1 Immunity to Toxoplasma$390,000
R01 · FY2010 · AI · contact PI
Pathogenic and Protective T Cells in Toxoplasmosis$390,000
R56 · FY2009 · AI · contact PI
Regulation of Type1 Immunity to Toxoplasma$390,000
R01 · FY2009 · AI · contact PI
Autophagic Defense Against Intracellular Parasites$195,000
R21 · FY2009 · AI · contact PI
Autophagic Defense Against Intracellular Parasites$228,400
R21 · FY2008 · AI · contact PI
Generation/Maintenance of Type 1 Immunity to Toxoplasma$219,544
R01 · FY2006 · AI · contact PI
Generation/Maintenance of Type 1 Immunity to Toxoplasma$82,008
R01 · FY2006 · AI · contact PI
Generation/Maintenance of Type 1 Immunity to Toxoplasma$311,580
R01 · FY2005 · AI
Generation/Maintenance of Type 1 Immunity to Toxoplasma$311,651
R01 · FY2004 · AI
Generation/Maintenance of Type 1 Immunity to Toxoplasma$274,750
R01 · FY2003 · AI
Generation/Maintenance of Type 1 Immunity to Toxoplasma$274,750
R01 · FY2002 · AI